Autres langues Applied DNA Sciences, Inc.

Actions

APDN

US03815U4094

Temps Différé Nasdaq Autres places de cotation 15:32:16 02/05/2024			Varia. 5j.	Varia. 1 janv.
4,11 ^USD	+1,99%		-17,80%	-66,68%

25/04	Applied DNA Sciences, Inc. reçoit un contrat de HDT Bio pour un programme de développement rapide de vaccins	CI
14/03	Applied DNA Sciences, Inc. présentera les plateformes Linea DNA et Linea IVT au 24e Congrès mondial annuel sur les vaccins	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program	26/04
Applied DNA Sciences, Inc. Receives Contract by HDT Bio for Rapid Vaccine Development Program	25/04
Certain Warrants of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.	03/04
Certain Options of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.	03/04
Certain Common Stock of Applied DNA Sciences, Inc. are subject to a Lock-Up Agreement Ending on 3-APR-2024.	03/04
Applied DNA to Showcase Linea DNA and Linea IVT Platforms at 24th Annual World Vaccine Congress	15/03
Applied DNA Sciences, Inc. to Showcase Linea DNA and Linea IVT Platforms At 24Th Annual World Vaccine Congress	14/03
Applied DNA Sciences Files Prospectus for Potential Secondary Stock Offerings	12/03
Applied DNA Sciences: Fiscal Q1 Earnings Snapshot	08/02
Earnings Flash (APDN) APPLIED DNA SCIENCES Reports Q1 Revenue $891,164	08/02
Applied DNA Sciences, Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023	08/02
Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules	01/02
Applied DNA Announces Joint Development Agreement to Integrate Linea IVT Platform into CDMO Kudo Biotechnology's mRNA Manufacturing Workflow	15/12
Applied DNA Sciences, Inc. Announces Joint Development Agreement to Integrate Linea IVT Platform into CDMO Kudo Biotechnology?s mRNA Manufacturing Workflow	14/12
Applied DNA Sciences: Fiscal Q4 Earnings Snapshot	07/12
Earnings Flash (APDN) APPLIED DNA SCIENCES Posts Q4 Revenue $779,736, vs. Street Est of $1.7M	07/12
Applied DNA Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	07/12
Applied DNA Sciences, Inc. Reports Earnings Results for the Full Year Ended September 30, 2023	07/12
Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023	06/12
Applied DNA Sciences, Inc. Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application	28/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Applied DNA Sciences, Inc.

Actions

APDN

US03815U4094

Autres langues

Filtres